Direct, indirect and total effects of 13-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in children in Navarra, Spain, 2001 to 2014: cohort and case–control study

Increase of serotypes 15A and 23B in IPD in Germany in the PCV13 vaccination era

(2015) Mark van der Linden et al.   BMC INFECTIOUS DISEASES

Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study

(2015) Pauline A Waight et al.   LANCET INFECTIOUS DISEASES

Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance

(2015) Matthew R Moore et al.   LANCET INFECTIOUS DISEASES

Impact of the pneumococcal conjugate vaccines on invasive pneumococcal disease in France, 2001–2012

(2015) A. Lepoutre et al.   VACCINE

Effectiveness of three pneumococcal conjugate vaccines to prevent invasive pneumococcal disease in Quebec, Canada

(2015) Geneviève Deceuninck et al.   VACCINE

Impact of 13-Valent Pneumococcal Conjugate Vaccination in Invasive Pneumococcal Disease Incidence and Mortality

(2014) Zitta Barrella Harboe et al.   CLINICAL INFECTIOUS DISEASES

Decreasing incidence and changes in serotype distribution of invasive pneumococcal disease in persons aged under 18 years since introduction of 10-valent and 13-valent conjugate vaccines in Portugal, July 2008 to June 2012

(2014) S I Aguiar et al.   Eurosurveillance

Reduction of Invasive Pneumococcal Disease 3 Years After the Introduction of the 13-Valent Conjugate Vaccine in the Oxfordshire Region of England

(2014) Catrin E. Moore et al.   JOURNAL OF INFECTIOUS DISEASES

Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study

(2014) Nick J Andrews et al.   LANCET INFECTIOUS DISEASES

Direct and Indirect Effects of PCV13 on Nasopharyngeal Carriage of PCV13 Unique Pneumococcal Serotypes in Massachusetts’ Children

(2014) Anita M. Loughlin et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Reduced incidence of invasive pneumococcal disease after introduction of the 13-valent conjugate vaccine in Navarre, Spain, 2001–2013

(2014) Marcela Guevara et al.   VACCINE

Vaccine effects and impact of vaccination programmes in post-licensure studies

(2013) Germaine Hanquet et al.   VACCINE

Impact of pneumococcal conjugate vaccines on nasopharyngeal carriage and invasive disease among unvaccinated people: Review of evidence on indirect effects

(2013) Stephanie M. Davis et al.   VACCINE

Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway

(2013) Anneke Steens et al.   VACCINE

Serotype-Specific Changes in Invasive Pneumococcal Disease after Pneumococcal Conjugate Vaccine Introduction: A Pooled Analysis of Multiple Surveillance Sites

(2013) Daniel R. Feikin et al.   PLOS MEDICINE

Immunization schedule of the Spanish Association of Pediatrics: 2012 recommendations

(2011) D. Moreno-Pérez et al.   ANALES DE PEDIATRIA

Observed differences in invasive pneumococcal disease epidemiology after routine infant vaccination

(2011) Mark H Rozenbaum et al.   Expert Review of Vaccines

Review on the immunogenicity and safety of PCV-13 in infants and toddlers

(2011) Marta C Nunes et al.   Expert Review of Vaccines

Serotype replacement in disease after pneumococcal vaccination

(2011) Daniel M Weinberger et al.   LANCET

Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine

(2011) Elizabeth Miller et al.   VACCINE

Pneumococcal Conjugate Vaccination and Nasopharyngeal Acquisition of Pneumococcal Serotype 19A Strains

(2010) Elske J. M. van Gils   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Changing epidemiology of invasive pneumococcal disease following increased coverage with the heptavalent conjugate vaccine in Navarre, Spain

(2009) M. Guevara et al.   CLINICAL MICROBIOLOGY AND INFECTION